 | • レポートコード：MRC2107A027 • 出版社/出版日：Transparency Market Research / 2021年5月10日 • レポート形態：英文、PDF、194ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprise Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、凍結乾燥注射剤の世界市場を広く調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、包装タイプ別（単回使用バイアル、ポイントオブケア再構成、特殊包装）分析、デリバリータイプ別分析、疾患別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場見通し ・凍結乾燥注射剤の世界市場規模：包装タイプ別（単回使用バイアル、ポイントオブケア再構成、特殊包装） ・凍結乾燥注射剤の世界市場規模：デリバリータイプ別 ・凍結乾燥注射剤の世界市場規模：疾患別 ・凍結乾燥注射剤の世界市場規模：エンドユーザー別 ・凍結乾燥注射剤の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Lyophilized Injectable Market – Scope of the Report
TMR’s report on the global lyophilized injectable market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global lyophilized injectable market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global lyophilized injectable market from 2021 to 2031.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global lyophilized injectable market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyophilized injectable market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global lyophilized injectable market. These serve as valuable tools for existing market players as well as entities interested in participating in the global lyophilized injectable market.
The report also delves into the competitive landscape of the global lyophilized injectable market. Key players operating in the global lyophilized injectable market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global lyophilized injectable market that have been profiled in this report.
Key Questions Answered in Lyophilized Injectable Market Report
What is the sales/revenue generated by lyophilized injectable providers across all regions during the forecast period?
What are the opportunities in the global lyophilized injectable market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which application segment is expected to generate the highest revenue globally in 2030?
What are the market positions of different companies operating in the global market?
Lyophilized Injectable Market – Research Objectives and Research Approach
The comprehensive report on the global lyophilized injectable market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of product.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global lyophilized injectable market in terms of type of packaging, type of delivery, indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global lyophilized injectable market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Lyophilized Injectable Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Lyophilized Injectable Market Analysis and Forecast, 2017–2031
5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Key Industry Developments
5.3. Pipeline Analysis
5.4. Top 10 Lyophilized Drug Products
5.5. Regulatory Scenario
6. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Packaging
6.1. Introduction & Definition
6.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
6.2.1. Single-use Vials
6.2.2. Point-of-care Reconstitution
6.2.3. Specialty Packaging
6.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging
7. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Delivery
7.1. Introduction & Definition
7.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
7.2.1. Prefilled Diluent Syringes
7.2.2. Proprietary Reconstitution Devices
7.2.3. Single-step Devices
7.2.4. Multi-step Devices
7.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery
8. Global Lyophilized Injectable Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
8.2.1. Autoimmune Diseases
8.2.2. Metabolic Conditions
8.2.3. Infectious Diseases
8.2.4. Others
8.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Indication
9. Global Lyophilized Injectable Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Specialty Clinics
9.2.4. Others
9.3. Global Lyophilized Injectable Market Attractiveness Analysis, by End-user
10. Global Lyophilized Injectable Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Region
11. North America Lyophilized Injectable Market Analysis and Forecast
11.1. Introduction
11.2. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
11.2.1. Single-use Vials
11.2.2. Point-of-care Reconstitution
11.2.3. Specialty Packaging
11.3. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
11.3.1. Prefilled Diluent Syringes
11.3.2. Proprietary Reconstitution Devices
11.3.3. Single-step Devices
11.3.4. Multi-step Devices
11.4. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
11.4.1. Autoimmune Diseases
11.4.2. Metabolic Conditions
11.4.3. Infectious Diseases
11.4.4. Others
11.5. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.5.4. Others
11.6. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America Lyophilized Injectable Market Attractiveness Analysis
11.7.1. By Type of Packaging
11.7.2. By Type of Delivery
11.7.3. By Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Lyophilized Injectable Market Analysis and Forecast
12.1. Introduction
12.2. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
12.2.1. Single-use Vials
12.2.2. Point-of-care Reconstitution
12.2.3. Specialty Packaging
12.3. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
12.3.1. Prefilled Diluent Syringes
12.3.2. Proprietary Reconstitution Devices
12.3.3. Single-step Devices
12.3.4. Multi-step Devices
12.4. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
12.4.1. Autoimmune Diseases
12.4.2. Metabolic Conditions
12.4.3. Infectious Diseases
12.4.4. Others
12.5. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.5.4. Others
12.6. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Lyophilized Injectable Market Attractiveness Analysis
12.7.1. By Type of Packaging
12.7.2. By Type of Delivery
12.7.3. By Indication
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Lyophilized Injectable Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
13.2.1. Single-use Vials
13.2.2. Point-of-care Reconstitution
13.2.3. Specialty Packaging
13.3. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
13.3.1. Prefilled Diluent Syringes
13.3.2. Proprietary Reconstitution Devices
13.3.3. Single-step Devices
13.3.4. Multi-step Devices
13.4. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
13.4.1. Autoimmune Diseases
13.4.2. Metabolic Conditions
13.4.3. Infectious Diseases
13.4.4. Others
13.5. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.5.4. Others
13.6. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Lyophilized Injectable Market Attractiveness Analysis
13.7.1. By Type of Packaging
13.7.2. By Type of Delivery
13.7.3. By Indication
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Lyophilized Injectable Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
14.2.1. Single-use Vials
14.2.2. Point-of-care Reconstitution
14.2.3. Specialty Packaging
14.3. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
14.3.1. Prefilled Diluent Syringes
14.3.2. Proprietary Reconstitution Devices
14.3.3. Single-step Devices
14.3.4. Multi-step Devices
14.4. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
14.4.1. Autoimmune Diseases
14.4.2. Metabolic Conditions
14.4.3. Infectious Diseases
14.4.4. Others
14.5. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.5.4. Others
14.6. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Lyophilized Injectable Market Attractiveness Analysis
14.7.1. By Type of Packaging
14.7.2. By Type of Delivery
14.7.3. By Indication
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Lyophilized Injectable Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
15.2.1. Single-use Vials
15.2.2. Point-of-care Reconstitution
15.2.3. Specialty Packaging
15.3. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
15.3.1. Prefilled Diluent Syringes
15.3.2. Proprietary Reconstitution Devices
15.3.3. Single-step Devices
15.3.4. Multi-step Devices
15.4. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
15.4.1. Autoimmune Diseases
15.4.2. Metabolic Conditions
15.4.3. Infectious Diseases
15.4.4. Others
15.5. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.5.4. Others
15.6. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis
15.7.1. By Type of Packaging
15.7.2. By Type of Delivery
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Position Analysis, by Company, 2019
16.2. Company Profiles
16.2.1. B. Braun Melsungen AG
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Growth Strategies
16.2.1.3. SWOT Analysis
16.2.2. Baxter International, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Growth Strategies
16.2.2.3. SWOT Analysis
16.2.3. BD
16.2.3.1. Company Overview (HQ, Business Segments)
16.2.3.2. Growth Strategies
16.2.3.3. SWOT Analysis
16.2.4. SCHOTT AG
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Growth Strategies
16.2.4.3. SWOT Analysis
16.2.5. Aristopharma Ltd.
16.2.5.1. Company Overview (HQ, Business Segments)
16.2.5.2. Growth Strategies
16.2.5.3. SWOT Analysis
16.2.6. Vetter Pharma
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Growth Strategies
16.2.6.3. SWOT Analysis
16.2.7. Jubilant HollisterStier LLC
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Growth Strategies
16.2.7.3. SWOT Analysis
Table 01: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 02: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 03: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 04: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 08: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 09: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 10: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 13: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 14: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 18: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 19: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 20: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 23: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 24: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 25: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031
Table 28: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031
Table 29: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 30: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031